Evidence map›Paper›PMID 33603920›Full record

ArticleCancer nanotechnology2021

Excretable, ultrasmall hexagonal NaGdF

Jossana A Damasco, Tymish Y Ohulchanskyy, Supriya Mahajan, Guanying Chen, Ajay Singh, Hilliard L Kutscher, Haoyuan Huang, Steven G Turowski, Joseph A Spernyak, Anurag K Singh and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer nanotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jossana A DamascoDepartment of Chemistry and Institute for Lasers, Photonics and Biophotonics, University At Buffalo, The State University of New York, Buffalo, NY 14260 USA.
Tymish Y OhulchanskyyDepartment of Chemistry and Institute for Lasers, Photonics and Biophotonics, University At Buffalo, The State University of New York, Buffalo, NY 14260 USA.
Supriya MahajanDepartment of Medicine, Division of Allergy, Immunology and Rheumatology, University At Buffalo, The State University of New York, Buffalo, NY 14203 USA.
Guanying ChenDepartment of Chemistry and Institute for Lasers, Photonics and Biophotonics, University At Buffalo, The State University of New York, Buffalo, NY 14260 USA.
Ajay SinghDepartment of Chemistry and Institute for Lasers, Photonics and Biophotonics, University At Buffalo, The State University of New York, Buffalo, NY 14260 USA.
Hilliard L KutscherDepartment of Chemistry and Institute for Lasers, Photonics and Biophotonics, University At Buffalo, The State University of New York, Buffalo, NY 14260 USA.
Haoyuan HuangDepartment of Biomedical Engineering, University At Buffalo, The State University of New York, Buffalo, NY 14260 USA.
Steven G TurowskiTranslational Imaging Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263 USA.
Joseph A SpernyakTranslational Imaging Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263 USA.
Anurag K SinghDepartment of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263 USA.
Jonathan F LovellDepartment of Biomedical Engineering, University At Buffalo, The State University of New York, Buffalo, NY 14260 USA.
Mukund SeshadriTranslational Imaging Shared Resource, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263 USA.
Paras N PrasadDepartment of Chemistry and Institute for Lasers, Photonics and Biophotonics, University At Buffalo, The State University of New York, Buffalo, NY 14260 USA.

Funding

University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
Institutional Career DevelopmentKL2TR001413 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI DUBOCOVICH, MARGARITA L · 2015 to 2024
$4.2M
NCATS NIH HHS KL2 TR001413NCATS NIH HHS UL1 TR001412
6 · The paper itself

Abstract

backgroundIn this study, we report on the synthesis, imaging, and radiosensitizing properties of ultrasmall β-NaGdF

resultsOur ultrasmall β-NaGdF

conclusionThese biocompatible and in vivo clearable ultrasmall NaGdF

Indexed as

Gadolinium nanoparticlesGlioblastomaMR/CT imaging probesRadiosensitizerTheranostics

Identifiers

PMID33603920
PMCPMC7864820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.